Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (22) , 6409-6421
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (9P20GM104932)
- National Institutes of Health
This publication has 60 references indexed in Scilit:
- Cdk5: a multifaceted kinase in neurodegenerative diseasesTrends in Cell Biology, 2012
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityNature Biotechnology, 2011
- Studying synergism of methyl linked cyclohexyl thiophenes with triazole: Synthesis and their cdk5/p25 inhibition activityEuropean Journal of Medicinal Chemistry, 2011
- Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitorsJournal of Molecular Modeling, 2010
- Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral SignalingCancer Research, 2010
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Making a neuron: Cdk5 in embryonic and adult neurogenesisTrends in Neurosciences, 2009
- Novel Method for Generating Structure-Based Pharmacophores Using Energetic AnalysisJournal of Chemical Information and Modeling, 2009
- Cdk5 deregulation in the pathogenesis of Alzheimer's diseaseTrends in Molecular Medicine, 2004